Application 204284
- Type
- ANDA
- Sponsor
- INVAGEN PHARMS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | ZOLMITRIPTAN | ZOLMITRIPTAN | TABLET;ORAL | 2.5MG | No | No |
| 002 | ZOLMITRIPTAN | ZOLMITRIPTAN | TABLET;ORAL | 5MG | No | No |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 31722-458 | ZOLMITRIPTAN | ZOLMITRIPTAN | Camber Pharmaceuticals Inc | ANDA | Current |
| 31722-459 | ZOLMITRIPTAN | ZOLMITRIPTAN | Camber Pharmaceuticals Inc | ANDA | Current |
| 69097-863 | Zolmitriptan | Zolmitriptan | Cipla USA Inc. | ANDA | Current |
| 69097-863 | Zolmitriptan | Zolmitriptan | Cipla USA Inc. | ANDA | Current |
| 69097-864 | Zolmitriptan | Zolmitriptan | Cipla USA Inc. | ANDA | Current |
| 69097-864 | Zolmitriptan | Zolmitriptan | Cipla USA Inc. | ANDA | Current |